4.7 Article

Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

RBM3 expression is upregulated by NF-κB p65 activity, protecting cells from apoptosis, during mild hypothermia

Ayako Ushio et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Article Oncology

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Su Yin Lim et al.

ONCOTARGET (2016)

Article Multidisciplinary Sciences

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance

Antonina V. Kurtova et al.

NATURE (2015)

Article Biochemistry & Molecular Biology

Nonsteroidal Anti-inflammatory Drugs Diclofenac and Celecoxib Attenuates Wnt/β-Catenin/Tcf Signaling Pathway in Human Glioblastoma Cells

Gangadhara Reddy Sareddy et al.

NEUROCHEMICAL RESEARCH (2013)

Article Oncology

The emerging role of CXCL10 in cancer (Review)

Mingli Liu et al.

ONCOLOGY LETTERS (2011)

Article Biochemistry & Molecular Biology

Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1

Shankar Jagadeesh et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Review Oncology

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

Sabine Groesch et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)